Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Net Cash Flow: 2018-2024

Historic Net Cash Flow for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$1.0 billion.

  • Legend Biotech's Net Cash Flow fell 88.72% to $31.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$186.8 million, marking a year-over-year increase of 63.07%. This contributed to the annual value of -$1.0 billion for FY2024, which is 329.96% down from last year.
  • Legend Biotech's Net Cash Flow amounted to -$1.0 billion in FY2024, which was down 329.96% from $444.8 million recorded in FY2023.
  • Legend Biotech's 5-year Net Cash Flow high stood at $444.8 million for FY2023, and its period low was -$1.0 billion during FY2024.
  • Over the past 3 years, Legend Biotech's median Net Cash Flow value was $90.8 million (recorded in 2022), while the average stood at -$162.4 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 389.66% in 2023, then plummeted by 329.96% in 2024.
  • Over the past 5 years, Legend Biotech's Net Cash Flow (Yearly) stood at $361.4 million in 2020, then plummeted by 35.77% to $232.1 million in 2021, then plummeted by 60.87% to $90.8 million in 2022, then soared by 389.66% to $444.8 million in 2023, then plummeted by 329.96% to -$1.0 billion in 2024.